HRT FINANCIAL LP - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 5 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$3,000
-50.0%
39,758
-14.4%
0.00%–
Q1 2022$6,000
-53.8%
46,4570.0%0.00%–
Q4 2021$13,000
-61.8%
46,4570.0%0.00%–
Q3 2021$34,000–46,457–0.00%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q3 2022
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders